Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test
Vancouver, British Columbia–(Newsfile Corp. – April 6, 2021) – Entheon Biomedical Corp. (CNSX:ENBI.CN) (FSE:1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces the launch of the industry’s first Psychedelics Genetic Test Kit, developed by wholly-owned subsidiary, HaluGen Life Sciences Inc. (“HaluGen”), and that it is now available […]
Core One Labs Vocan Expands Product Commercialization Team
VANCOUVER, BC / ACCESSWIRE / April 6, 2021 / Core One Labs Inc. (CNSX:COOL.CN)(OTCPINK:CLABF)(Frankfurt:LD62) (WKN:A2P8K3) (the “Company” or “Core One”) is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. (“Vocan”) has expanded its product commercialization team, adding Dr. Elizabeth Matthews as Head of Scientific and Regulatory Affairs. Dr. Matthews will oversee research and development, […]
